透皮芬太尼撤药 - Suppr

Suppr

超能文献

Withdrawal with transdermal fentanyl.

作者信息

Higgs C M, Vella-Brincat J

出版信息

J Pain Symptom Manage. 1995 Jan;10(1):4-5. doi: 10.1016/0885-3924(94)00060-X.

DOI:10.1016/0885-3924(94)00060-X

PMID:7714347

Abstract

摘要

相似文献

Withdrawal with transdermal fentanyl.透皮芬太尼撤药

J Pain Symptom Manage. 1995 Jan;10(1):4-5. doi: 10.1016/0885-3924(94)00060-X.

Transdermal fentanyl and the opioid withdrawal syndrome.透皮芬太尼与阿片类药物戒断综合征。

Palliat Med. 1996 Oct;10(4):348.

Transdermal fentanyl and the opioid withdrawal syndrome.透皮芬太尼与阿片类戒断综合征。

Palliat Med. 1996 Oct;10(4):347-8.

Withdrawal symptoms during chronic transdermal fentanyl administration managed with oral methadone.

J Pain Symptom Manage. 2004 Mar;27(3):191-4. doi: 10.1016/j.jpainsymman.2003.12.003.

Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery.芬太尼离子导入透皮系统（ITS）与静脉自控镇痛（IV PCA）联合吗啡用于腹部或盆腔手术后疼痛管理的疗效和安全性。

Pain Med. 2007 Nov-Dec;8(8):657-68. doi: 10.1111/j.1526-4637.2006.00257.x.

Do patients prefer transdermal fentanyl or sustained-release oral morphine for treatment of chronic non-cancer pain?对于慢性非癌性疼痛的治疗，患者更倾向于使用透皮芬太尼还是缓释口服吗啡？

J Fam Pract. 2001 Oct;50(10):897.

Therapy switching in patients receiving long-acting opioids.接受长效阿片类药物治疗的患者的治疗转换

Ann Pharmacother. 2004 Mar;38(3):389-95. doi: 10.1345/aph.1D109. Epub 2004 Jan 12.

Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.癌症疼痛患者从口服吗啡早期转换为透皮芬太尼治疗

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1545-8.

[Transdermal fentanyl].

Rev Med Brux. 1998 Apr;19(2):83-6.

Dosage of transdermal fentanyl.

Clin Pharm. 1993 Oct;12(10):718.

引用本文的文献

Transdermal opioids for cancer pain.用于癌症疼痛的透皮阿片类药物。

Health Qual Life Outcomes. 2006 Mar 31;4:24. doi: 10.1186/1477-7525-4-24.

Practice guidelines for transdermal opioids in malignant pain.恶性疼痛中经皮阿片类药物的实践指南。

Drugs. 2004;64(23):2629-38. doi: 10.2165/00003495-200464230-00002.

Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.透皮芬太尼治疗慢性疼痛的获益-风险评估。

Drug Saf. 2003;26(13):951-73. doi: 10.2165/00002018-200326130-00004.

Strategies for the treatment of cancer pain in the new millennium.新千年癌症疼痛的治疗策略。

Drugs. 2001;61(7):955-77. doi: 10.2165/00003495-200161070-00005.

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.经皮阿片类药物的临床药代动力学：聚焦于经皮芬太尼

Clin Pharmacokinet. 2000 Jan;38(1):59-89. doi: 10.2165/00003088-200038010-00004.

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.透皮芬太尼。其药理特性及疼痛控制治疗效果综述。

Drugs. 1997 Jan;53(1):109-38. doi: 10.2165/00003495-199753010-00011.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验